Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Adaptive NK cells can effectively target ovarian cancer, study shows April 28, 2025 Organ-on-chip model advances study of sexually transmitted infections April 3, 2026 New NIH grants fuel research in oral cancer treatment and pain relief November 7, 2025